Co-Authors
This is a "connection" page, showing publications co-authored by TAMER MOHAMED and ABOU BAKR SALAMA.
Connection Strength
3.627
-
Editorial: Recent advances in cardiotoxicity testing, volume II. Front Pharmacol. 2024; 15:1414373.
Score: 0.877
-
Controlled and Targeted Drug Delivery Using Smart Nanovectors. Int J Drug Discov Pharm. 2023 Mar; 2(1):84-90.
Score: 0.812
-
Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model. Mol Cell Biochem. 2023 Jun; 478(6):1245-1250.
Score: 0.790
-
Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats. Cardiovasc Res. 2024 03 13; 120(2):152-163.
Score: 0.217
-
A novel small molecule inhibitor of p38? MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation. Br J Pharmacol. 2023 12; 180(24):3271-3289.
Score: 0.209
-
Biomimetic cardiac tissue culture model (CTCM) to emulate cardiac physiology and pathophysiology ex vivo. Commun Biol. 2022 09 09; 5(1):934.
Score: 0.196
-
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure. Circulation. 2022 04 26; 145(17):1339-1355.
Score: 0.187
-
Induced Cardiomyocyte Proliferation: A Promising Approach to Cure Heart Failure. Int J Mol Sci. 2021 Jul 19; 22(14).
Score: 0.181
-
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity. NPJ Regen Med. 2025 Jan 11; 10(1):1.
Score: 0.058
-
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity. Res Sq. 2023 Nov 30.
Score: 0.053
-
Cell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activation. Redox Biol. 2021 10; 46:102094.
Score: 0.045